Pascale David-Pierson

发表

Novel orally active, dibenzazepinone-based γ-secretase inhibitors

Guido Galley, Jens-Uwe Peters, J. Peters, 2007 .

β-Secretase (BACE1) inhibitors with high in vivo efficacy suitable for clinical evaluation in Alzheimer's disease.

Wolfgang Guba, Harald Mauser, Mark Rogers-Evans, 2013, Journal of medicinal chemistry.

Benzodioxoles: novel cannabinoid-1 receptor inverse agonists for the treatment of obesity.

Wolfgang Guba, Gisbert Schneider, Jochem Alsenz, 2008, Journal of medicinal chemistry.